Calpain activity and muscle wasting in sepsis
- 1 October 2008
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 295 (4), E762-E771
- https://doi.org/10.1152/ajpendo.90226.2008
Abstract
Muscle wasting in sepsis reflects activation of multiple proteolytic mechanisms, including lyosomal and ubiquitin-proteasome-dependent protein breakdown. Recent studies suggest that activation of the calpain system also plays an important role in sepsis-induced muscle wasting. Perhaps the most important consequence of calpain activation in skeletal muscle during sepsis is disruption of the sarcomere, allowing for the release of myofilaments (including actin and myosin) that are subsequently ubiquitinated and degraded by the 26S proteasome. Other important consequences of calpain activation that may contribute to muscle wasting during sepsis include degradation of certain transcription factors and nuclear cofactors, activation of the 26S proteasome, and inhibition of Akt activity, allowing for downstream activation of Foxo transcription factors and GSK-3β. The role of calpain activation in sepsis-induced muscle wasting suggests that the calpain system may be a therapeutic target in the prevention and treatment of muscle wasting during sepsis. Furthermore, because calpain activation may also be involved in muscle wasting caused by other conditions, including different muscular dystrophies and cancer, calpain inhibitors may be beneficial not only in the treatment of sepsis-induced muscle wasting but in other conditions causing muscle atrophy as well.Keywords
This publication has 118 references indexed in Scilit:
- Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin‐1The Journal of Physiology, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Prevention of unloading-induced atrophy by vitamin E supplementation: Links between oxidative stress and soleus muscle proteolysis?Free Radical Biology & Medicine, 2007
- FOXO transcription factorsCurrent Biology, 2007
- Spatial Localization of m-Calpain to the Plasma Membrane by Phosphoinositide Biphosphate Binding during Epidermal Growth Factor Receptor-Mediated ActivationMolecular and Cellular Biology, 2006
- Novel aspects on the regulation of muscle wasting in sepsisThe International Journal of Biochemistry & Cell Biology, 2005
- Treatment of cultured myotubes with the calcium ionophore A23187 increases proteasome activity via a CaMK II-caspase-calpain–dependent mechanismSurgery, 2004
- Molecular Regulation of Muscle Cachexia: It May Be More Than the ProteasomeBiochemical and Biophysical Research Communications, 2002
- Identification of an endogenous activator of calpain in rat skeletal muscleBiochemical and Biophysical Research Communications, 1990
- Isovalerylcarnitine is a specific activator of the high calcium requiring calpain formsBiochemical and Biophysical Research Communications, 1990